Table 1.
Differential diagnostic components for workup of patients with unexplained recurrent angioedema [16]
| Urticaria | Family history | C1INH, C4 | Responsive to antihistamines | Onset > 40, low C1q | FXII genetic mutation | Diagnosis |
|---|---|---|---|---|---|---|
| Yes | Mast cell-mediated or idiopathic angioedema | |||||
| No | Yes (75% of cases) | Lowa | No | HAE-C1INH | ||
| No | Yes or No | Normalb | Yes | Idiopathic histaminergic angioedema | ||
| No | No | Normalb | No | Idiopathic non-histaminergic angioedema | ||
| No | Yes | Normalb | No | Yes | HAE-FXII | |
| No | Yes | Normalb | No | No | HAE-U | |
| No | No | Lowa | No | Yes | Acquired C1INH deficiency |
C1INH C1 inhibitor, HAE hereditary angioedema, HAE-C1INH hereditary angioedema due to C1 inhibitor deficiency, HAE-FXII hereditary angioedema with F12 mutation, HAE-U hereditary angioedema, unknown
aLow (< 50% of normal) C1INH antigenic levels and/or low (< 50% of normal) functional C1INH activity (low C4 levels and normal antigenic C1INH levels should prompt functional C1INH activity assessment)
bNormal C1INH antigenic levels and C1INH functional activity